Mechanisms of depressed conduction from long-term amiodarone therapy in canine myocardium

J. H. Levine, E. N. Moore, A. H. Kadish, H. F. Weisman, C. W. Balke, R. F. Hanich, J. F. Spear

Research output: Contribution to journalArticlepeer-review

27 Scopus citations


Amiodarone therapy leads to a significant impairment in myocardial conduction, yet it causes only a modest decrease in the maximum rate of depolarization of the action potential (dV/dT). To determine whether the decrease in dV/dT solely accounts for the impaired myocardial conduction or whether passive membrane properties may also be involved, we studied 21 ventricular epicardial tissues from 14 beagles; six dogs received long-term treatment (3-6 weeks) of amiodarone orally, and the remaining dogs served as controls. Amiodarone therapy was associated with a decrease in conduction velocity (0.41 ± 0.15 vs. 0.56 ± 0.05 m/sec; p < 0.01). There was a trend toward a decrease in dV/dT and a significant decrease in the space constant (0.69 ± 0.27 vs. 1.05 ± 0.25 mm; p = 0.01), of which the latter correlated closely with the decrease in conduction velocity measured in the amiodarone-treated tissues (r = 0.85, p < 0.05). These data indicate that the decrease in myocardial conduction velocity caused by amiodarone is primarily due to effects on overall resistance to passive current flow rather than effects on the inward sodium current.

Original languageEnglish
Pages (from-to)684-691
Number of pages8
Issue number3 I
StatePublished - 1988


Dive into the research topics of 'Mechanisms of depressed conduction from long-term amiodarone therapy in canine myocardium'. Together they form a unique fingerprint.

Cite this